• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

CSNK1A1L (NM_145203) Human Over-expression Lysate

Catalog number LS122011

Discontinued

Price for LS122011

Sign In for Pricing

Size / count 100 µg

This variant is discontinued and cannot be added to your cart.

About this product

Transient overexpression lysate of casein kinase 1, alpha 1-like (CSNK1A1L)

Specifications

Catalog number
LS122011
Size / count
100 µg
Dry ice
Yes
Hazardous
No
Discontinued
Yes
Gene Name
CSNK1A1L
UniProt
Q8N752
Reactivity
Human
Source
HEK293T
Shipping Conditions
Due to dry ice shipping issues, this product is temporarily not available to distributors outside of the United States.

Frequently Asked Questions

What is the catalog number for CSNK1A1L (NM_145203) Human Over-expression Lysate?

The catalog number for CSNK1A1L (NM_145203) Human Over-expression Lysate is LS122011.

Is CSNK1A1L (NM_145203) Human Over-expression Lysate in stock?

CSNK1A1L (NM_145203) Human Over-expression Lysate is currently made to order / not held in immediate stock. Contact us for lead time.

Are there any special shipping requirements for CSNK1A1L (NM_145203) Human Over-expression Lysate?

CSNK1A1L (NM_145203) Human Over-expression Lysate is requires dry ice shipping.

Where can I find the safety data sheet (SDS/MSDS) for CSNK1A1L (NM_145203) Human Over-expression Lysate?

The safety data sheet for CSNK1A1L (NM_145203) Human Over-expression Lysate is available here: https://www.bosterbio.com/msds?sku=LS122011.

What is CSNK1A1L (NM_145203) Human Over-expression Lysate used for?

Transient overexpression lysate of casein kinase 1, alpha 1-like (CSNK1A1L)

What applications has this product been validated for?

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

How do I reconstitute this lyophilized product?

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

What is the recommended incubation time for this antibody?

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

You Might Also Like
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470391-100
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740977-500
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940679-500
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740026-500
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401052-100
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC880645-100
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470717-500
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040857-100